RhoGAM prevents Rh sensitization, but pooled donor plasma and post-2021 mRNA/spike findings raise safety questions that aren’t addressed in the FDA insert. This article examines the FDA label, spike-persistence data from studies and whistleblower reports, mRNA vaccine trial controversies, and practical steps to weigh benefits vs. risks with your clinician.

Amyloid fibroids were found in a 3 year old child after they were exposed to mRNA COVID-19 vaccines in utero. In this article, I explore the current research and solutions regarding dissolving these kinds of amyloid micro clots and which of these therapeutics would likely be safe enough to use with children.

This is an examination of the current research and peer-reviewed science, not medical advice.

SV40, a polyomavirus once discovered in monkeys and now controversially used in COVID-19 mRNA treatments and gene therapy, has been linked to various cancers in humans. This article critically examines the safety concerns, ethical implications, and regulatory oversights surrounding the use of SV40 in modern genetic therapies.